Drug Type Small molecule drug |
Synonyms Ceftriaxone Sodium and Sulbactam Sodium, Ceftriaxone Sodium and Tazobactam Sodium, 头孢曲松钠舒巴坦钠 |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (28 Jan 2011), |
Regulation- |
Molecular FormulaC18H20N8NaO8S3 |
InChIKeyKFQRYHQOZUTRQJ-BBJOQENWSA-N |
CAS Registry104376-79-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bacterial Infections | China | 28 Jan 2011 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | Phase 3 | China | 22 Mar 2013 |





